Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: A 7-day observational study of trauma patients

Critical Care

Volumn 18, Issue 4, 2014, Pages

  Schöchl, Herbert ^a,b   Voelckel, Wolfgang ^a   Maegele, Marc ^c   Kirchmair, Lukas ^a   Schlimp, Christoph J ^b  

^a AUVA Trauma Centre   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; HEMOGLOBIN; PROTHROMBIN COMPLEX; THROMBIN; THROMBOCYTE CONCENTRATE; BLOOD CLOTTING FACTOR; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX CONCENTRATES;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD SAMPLING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; ERYTHROCYTE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBOCYTE COUNT; TRAUMA INDUCED COAGULOPATHY; BLOOD; COHORT ANALYSIS; DRUG EFFECTS; HEMOSTASIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TRENDS; WOUNDS AND INJURIES;

ADULT; BLOOD COAGULATION FACTORS; COHORT STUDIES; FEMALE; HEMOSTASIS; HEMOSTATICS; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTHROMBIN TIME; THROMBIN; WOUNDS AND INJURIES;

EID: 84905911567     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13982     Document Type: Article

References (66)

1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130. 10.1097/01.TA.0000069184.82147.06, 12813333.
2. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304. 10.1016/j.injury.2006.10.003, 17214989.
3. Johansson PI, Sørensen AM, Larsen CF, Windeløv NA, Stensballe J, Perner A, Rasmussen LS, Ostrowski SR. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 2013, 53:3088-3099. 10.1111/trf.12214, 23614333.
4. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:231-240. 10.1016/j.blre.2009.07.003, 3159517, 19695750.
5. Dirks J, Jørgensen H, Jensen CH, Ostrowski SR, Johansson PI. Blood product ratio in acute traumatic coagulopathy-effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med 2010, 18:65. 10.1186/1757-7241-18-65, 3004812, 21138569.
6. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH, . PROMMTT Study Group The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013, 148:127-136. 10.1001/2013.jamasurg.387, 3740072, 23560283, PROMMTT Study Group.
7. Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE, Holcomb JB, Cotton BA. An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 2013, 148:170-175. 10.1001/jamasurgery.2013.414, 3800103, 23426594.
8. Theusinger OM, Baulig W, Seifert B, Emmert MY, Spahn DR, Asmis LM. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth 2011, 106:505-511. 10.1093/bja/aer003, 21310721.
9. Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011, 45:990-999. 10.1345/aph.1Q096, 21730276.
10. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: Prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011, 15:201. 10.1186/cc9311, 3222012, 21345266.
11. Tanaka KA, Szlam F. Treatment of massive bleeding with prothrombin complex concentrate: argument for. J Thromb Haemost 2010, 8:2589-2591. 10.1111/j.1538-7836.2010.04052.x, 20831614.
12. Scho¨chl H, Maegele M, Solomon C, Gorlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012, 20:15. 10.1186/1757-7241-20-15, 3306198, 22364525.
13. Grassetto A, De Nardin M, Ganzerla B, Geremia M, Saggioro D, Serafini E, Zampieri S, Toffoli M, Penzo D, Bossi A, Maggiolo C. ROTEM®-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice. Italy Crit Care 2012, 16:428.
14. Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013, 44:209-216. 10.1016/j.injury.2012.08.047, 23000050.
15. Scho¨chl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14:R55. 10.1186/cc8948, 2887173, 20374650.
16. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice?. Curr Opin Anaesthesiol 2009, 22:305-312. 10.1097/ACO.0b013e3283212c7c, 19390257.
17. Godier A, Susen S, Samama CM. Treatment of massive bleeding with prothrombin complex concentrate: argument against. J Thromb Haemost 2010, 8:2592-2595. 10.1111/j.1538-7836.2010.04062.x, 20860676.
18. Lin DM, Murphy LS, Tran MH. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev 2013, 27:91-104. 10.1016/j.tmrv.2013.01.002, 23462530.
19. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009, 102:345-354. 10.1093/bja/aen391, 2642652, 19168856.
20. Honickel M, Rieg A, Rossaint R, Braunschweig T, Spronk HM, ten Cate H, van Oerle R, Tolba R, Grottke O. Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thromb Haemost 2011, 106:724-733. 10.1160/TH11-02-0101, 21901227.
21. Mitterlechner T, Innerhofer P, Streif W, Lo¨dl M, Danninger T, Klima G, Hansson K, Fries D. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011, 9:729-737. 10.1111/j.1538-7836.2011.04211.x, 21255250.
22. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy-a porcine model. Br J Anaesth 2006, 97:460-467. 10.1093/bja/ael191, 16885172.
23. Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 2008, 12:R105. 10.1186/cc6987, 2575594, 18706082.
24. Nienaber U, Innerhofer P, Westermann I, Scho¨chl H, Attal R, Breitkopf R, Maegele M. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011, 42:697-701. 10.1016/j.injury.2010.12.015, 21392760.
25. Schick KS, Fertmann JM, Jauch KW, Hoffmann JN. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009, 13:R191. 10.1186/cc8186, 2811941, 19948037.
26. Scho¨chl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011, 15:R83. 10.1186/cc10078, 3219338, 21375741.
27. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011, 118:1943-1951. 10.1182/blood-2011-03-343046, 21670472.
28. Holley AB, Petteys S, Mitchell JD, Holley PR, Collen JF. Thromboprophylaxis and VTE rates in soldiers wounded in Operation Enduring Freedom and Operation Iraqi Freedom. Chest 2013, 144:966-973. 10.1378/chest.12-2879, 23539197.
29. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994, 331:1601-1606. 10.1056/NEJM199412153312401, 7969340.
30. Scho¨chl H, Voelckel W, Grassetto A, Schlimp CJ. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg 2013, 74:1587-1598. 10.1097/TA.0b013e31828c3171, 23694891.
31. Baxter Summary of product characteristics - Prothromplex Total 600 IU. [http://mri.medagencies.org/download/AT_H_0373_001_FinalSPC.pdf]. Accessed 21 July 2014, Baxter.
32. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Meji´a-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376:23-32.
33. Huber-Wagner S, Lefering R, Qvick LM, Korner M, Kay MV, Pfeifer KJ, Reiser M, Mutschler W, Kanz KG. Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre study. Lancet 2009, 373:1455-1461. 10.1016/S0140-6736(09)60232-4, 19321199.
34. Schaden E, Hoerburger D, Hacker S, Kraincuk P, Baron DM, Kozek-Langenecker S. Fibrinogen function after severe burn injury. Burns 2012, 38:77-82. 10.1016/j.burns.2010.12.004, 22113102.
35. Sørensen JV, Jensen HP, Rahr HB, Borris LC, Lassen MR, Fedders O, Haase JP, Knudsen F. Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction. Haemostasis 1993, 23:91-97.
36. Chapman SA, Irwin ED, Beal AL, Kulinski NM, Hutson KE, Thorson MA. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Ann Pharmacother 2011, 45:869-875. 10.1345/aph.1P605, 21775690.
37. Sarode R, Milling TJ, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study. Circulation 2013, 128:1234-1243.
38. Joseph B, Amini A, Friese RS, Houdek M, Hays D, Kulvatunyou N, Wynne J, O'Keeffe T, Latifi R, Rhee P. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012, 72:828-834.
39. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Ferna´ndez-Monde´jar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013, 17:R76. 10.1186/cc12685, 4056078, 23601765.
40. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009, 102:793-799. 10.1093/bja/aep098, 19420005.
41. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 2007, 26:141-148. 10.1111/j.1365-2036.2007.03369.x, 17593061.
42. Mann KG, Brummel K, Butenas S. What is all that thrombin for?. J Thromb Haemost 2003, 1:1504-1514. 10.1046/j.1538-7836.2003.00298.x, 12871286.
43. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009, 49:2652-2660. 10.1111/j.1537-2995.2009.02335.x, 19682336.
44. Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011, 107:378-387. 10.1093/bja/aer158, 21705350.
45. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002, 88:576-582.
46. Hanker-Dusel C, Grundmann C, Eich S, Seitz R, Ko¨nig H. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis 2004, 15:405-411. 10.1097/01.mbc.0000114437.81125.2b, 15205589.
47. Grundman C, Plesker R, Kusch M, Hanschmann KM, Eich S, Seitz R, Konig H. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence. Thromb Haemost 2005, 94:1338-1339.
48. Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010, 8:149-154. 2906185, 20671873.
49. Grottke O, Rossaint R, Henskens Y, van Oerle R, Ten Cate H, Spronk HM. Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model. PLoS One 2013, 8:e64100. 10.1371/journal.pone.0064100, 3656958, 23696866.
50. Kalina U, Bickhard H, Schulte S. Biochemical comparison of seven commercially available prothrombin complex concentrates. Int J Clin Pract 2008, 62:1614-1622. 10.1111/j.1742-1241.2008.01859.x, 18691229.
51. Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001, 29:489-493.
52. Butenas S, van't Veer C, Mann KG. " Normal" thrombin generation. Blood 1999, 94:2169-2178.
53. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012, 3. CD005011.
54. Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass. Br J Anaesth 2014, 112:319-27. 10.1093/bja/aet355, 24193321.
55. Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost 2007, 98:790-797.
56. Sniecinski R, Szlam F, Chen EP, Bader SO, Levy JH, Tanaka KA. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg 2008, 106:713-718. 10.1213/ane.0b013e3181608f7c, 18292407.
57. Hellstern P, Halbmayer WM, Kohler M, Seitz R, Muller-Berghaus G. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Thromb Res 1999, 95:S3-S6. 10.1016/S0049-3848(99)00077-8, 10499902.
58. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009, 7:795-802. 10.1111/j.1538-7836.2009.03331.x, 19320829.
59. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009, 102:137-144.
60. Solomon C, Hagl C, Rahe-Meyer N. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth 2013, 110:947-956. 10.1093/bja/aes576, 3657602, 23388508.
61. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sorensen B, Hagl C, Pichlmaier M. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013, 118:40-50. 10.1097/ALN.0b013e3182715d4d, 23249928.
62. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009, 20:535-540. 10.1097/MBC.0b013e32832da1c5, 19710609.
63. Martini J, Maisch S, Pilshofer L, Streif W, Martini W, Fries D. Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs. Transfusion 2014, 54:149-157. 10.1111/trf.12241, 23672536.
64. Dutton RP, Parr M, Tortella BJ, Champion HR, Bernard GR, Boffard K, Bouillon B, Croce MA, Dimsits J, Holcomb JB, Leppaniemi A, Vincent JL, Hauser CJ. Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial. J Trauma 2011, 71:12-19. 10.1097/TA.0b013e31821a42cf, 21610529.
65. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S-453S. 10.1378/chest.08-0656, 18574271.
66. Hanke AA, Joch C, Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth 2013, 110:764-772. 10.1093/bja/aes501, 23335567.